Home > Compound List > Product Information
Conjugated Estrogens_Molecular_structure_CAS_438-67-5)
Click picture or here to close

Conjugated Estrogens

Catalog No. DB00286 Name DrugBank
CAS Number 438-67-5 Website http://www.ualberta.ca/
M. F. C18H21NaO5S Telephone (780) 492-3111
M. W. 372.41111 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 171

SYNONYMS

IUPAC name
sodium (1S,10R,11S,15S)-15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-5-yl sulfate
IUPAC Traditional name
potassium estrone 3-sulfate(1-)
Brand Name
Evex
Conestoral
Hyhorin
Par Estro
Premarin
Prempro/Premphase
Prempro
Morestin
Premarin tabs
Premarin Vaginal
Synonyms
Estrone Sulphate
Estrogens
Estrone Sodium Sulfate
Estrone Sulfate Sodium
Estrone Estrone Hydrogen Sulfate
Estrone-sulfate
Estrone Sulfate
Estrone Hydrogen Sulfate
Oestrone Sulphate
Sodium Estrone Sulfate

DATABASE IDS

CAS Number 438-67-5
PubChem CID 23667301
PubChem SID 46505680

PROPERTIES

Solubility 0.0036 mg/ml

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Conjugated estrogens, a mixture of the water-soluble salts of sulfate esters from estrone, equilin, 17 α-dihydroequilin, and other related steroids, may be derived from pregnant equine urine or yam and soy plants. Estrogens are important in the development and maintenance of the female reproductive system and secondary sex characteristics.
Indication For the treatment of moderate to severe vasomotor symptoms associated with the menopause, atrophic vaginitis, osteoporosis, hypoestrogenism due to hypogonadism, castration, primary ovarian failure, breast cancer (for palliation only), and Advanced androgen-dependent carcinoma of the prostate (for palliation only)
Pharmacology Conjugated estrogens, a mixture of the water soluble salts of sulfate esters from estrone, equilin, 17 α-dihydroequilin, and other related steroids, may be derived from pregnant equine urine or yam and soy plants. Estrogens are important in the development and maintenance of the female reproductive system and secondary sex characteristics. They promote growth and development of the vagina, uterus, and fallopian tubes, and enlargement of the breasts. Indirectly, they contribute to the shaping of the skeleton, maintenance of tone and elasticity of urogenital structures, changes in the epiphyses of the long bones that allow for the pubertal growth spurt and its termination, growth of axillary and pubic hair, and pigmentation of the nipples and genitals. Decline of estrogenic activity at the end of the menstrual cycle can bring on menstruation, although the cessation of progesterone secretion is the most important factor in the mature ovulatory cycle. However, in the preovulatory or nonovulatory cycle, estrogen is the primary determinant in the onset of menstruation. Estrogens also affect the release of pituitary gonadotropins. The pharmacologic effects of conjugated estrogens are similar to those of endogenous estrogens.
Toxicity Nausea and vomiting
Affected Organisms
Humans and other mammals
Biotransformation Hepatic
Absorption Well absorbed
Half Life 7.4 hours
Protein Binding 90% bound to plasma proteins
Elimination Estradiol, estrone, and estriol are excreted in the urine, along with glucuronide and sulfate conjugates. Exogenous estrogens are metabolized in the same manner as endogenous estrogens.
External Links
RxList
Drugs.com

REFERENCES